---
title: "LIFERIVER: Plans to implement the 2025 valuation enhancement plan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229571153.md"
description: "LIFERIVER (688317) will implement a valuation enhancement plan in 2025, as its stock has closed below net asset value per share for 12 consecutive months. The plan includes measures to improve operational efficiency, repurchase shares, distribute cash dividends, strengthen investor relations, enhance information disclosure, establish incentive mechanisms, seek merger and acquisition opportunities, and encourage management to hold shares, in order to enhance the company's investment value"
datetime: "2025-02-25T11:32:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229571153.md)
  - [en](https://longbridge.com/en/news/229571153.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229571153.md)
generator: "portal-rs"
---

# LIFERIVER: Plans to implement the 2025 valuation enhancement plan

On the evening of February 25, LIFERIVER announced that from January 1 to December 31, 2024, the closing price of the company's stock has been below the audited net assets per share attributable to shareholders of the listed company for the most recent accounting year for 12 consecutive months, which falls under the circumstances that require the formulation of a valuation enhancement plan. On February 24, 2025, the company's board of directors reviewed and approved the "Proposal on the Valuation Enhancement Plan for 2025." In 2025, the company plans to enhance its investment value through measures such as improving operational efficiency and profitability, actively implementing share repurchases, maintaining continuous cash dividends, strengthening investor relations management, enhancing the quality of information disclosure, establishing a sound long-term incentive mechanism, actively seeking merger and acquisition opportunities, and encouraging controlling shareholders, actual controllers, directors, and senior management to hold the company's shares for the long term

### Related Stocks

- [688317.CN](https://longbridge.com/en/quote/688317.CN.md)

## Related News & Research

- [09:10 ETLAIKA and Big Brothers Big Sisters of Greater Los Angeles Launch National "Wildwood Heroes" Campaign Celebrating Courage Beyond the Screen](https://longbridge.com/en/news/297920335.md)
- [NEJM publishes Phase 1/2 clinical data on daraxonrasib](https://longbridge.com/en/news/297858394.md)
- [Fosun Pharma subsidiary Shanghai Fosun Pharmaceutical Industrial Development wins China approval for new Luvometinib use in adult NF1 tumors](https://longbridge.com/en/news/297890174.md)
- [Biohit says scientific review backs serum biomarker triage to target endoscopy for gastric cancer risk](https://longbridge.com/en/news/297887371.md)
- [BCAL Diagnostics Builds Early Cancer Detection Platform as Test Uptake Grows](https://longbridge.com/en/news/297849557.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**